Paper34480904
Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections.
Kaur B and 4 others. Int J Biol Macromol, 2021. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections. Papers, record 34480904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34480904
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| Drug Resistance, Multiple, Bacterial | Major topic |
| Quorum Sensing | Major topic |
| Staphylococcal Infections | Major topic |
| Biofilms |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42848138 | Integrated in-silico and in-vitro evaluation of silybin as a potential quorum-sensing modulator against Acinetobacter baumannii and Staphylococcus aureus. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42848138 | PubMed |
| 42821095 | Preventive Activity of Paroxetine Against the Formation of Mixed Biofilms of Candida albicans and Staphylococcus aureus on Peripheral Venous Catheters. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42821095 | PubMed |
| 41769086 | Enhanced antibacterial activity of antimicrobial peptide-antibiotic combinations against multidrug-resistant bacteria. | FEMS Microbes | 2026 | https://conductscience.org/library/papers/41769086 | PubMed |
| 41518477 | The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/41518477 | PubMed |
| 41244988 | Network analysis of antimicrobial resistance in Staphylococcus aureus: characterization of hub genes and their functional implications. | NAR Genom Bioinform | 2025 | https://conductscience.org/library/papers/41244988 | PubMed |
| 41144286 | Targeting quorum sensing: natural product-based inhibition and quenching for antimicrobial strategies. | Future Microbiol | 2025 | https://conductscience.org/library/papers/41144286 | PubMed |
| 40849622 | Structural and functional analysis of the accessory gene regulators of Staphylococcus aureus and Staphylococcus epidermidis: an in Silico approach. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40849622 | PubMed |
| 40572502 | Tripterhyponoid A from Tripterygium hypoglaucum Inhibiting MRSA by Multiple Mechanisms. | Molecules | 2025 | https://conductscience.org/library/papers/40572502 | PubMed |
| 40510673 | Genomic epidemiology and characterization of Staphylococcus aureus isolates from raw milk in Jilin, China: evidence of contamination with optrA-positive, cfrA-positive, and poxtA-positive strains and human-livestock transmission. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40510673 | PubMed |
| 40314822 | Synergistic pathogenesis: exploring biofilms, efflux pumps and secretion systems in Acinetobacter baumannii and Staphylococcus aureus. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/40314822 | PubMed |
| 40193824 | AgrC biotinylation inhibits Staphylococcus aureus infection. | PLoS One | 2025 | https://conductscience.org/library/papers/40193824 | PubMed |
| 40192467 | Identification and characterization of a novel major facilitator superfamily (MFS) efflux pump conferring multidrug resistance in Staphylococcus aureus and Staphylococcus epidermidis. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40192467 | PubMed |
| 40153130 | Potential activity of paroxetine alone and associated with oxacillin as an alternative to prevent Staphylococcus aureus biofilm formation in catheters. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/40153130 | PubMed |
| 40063617 | Reciprocal regulation between Acinetobacter baumannii and Enterobacter cloacae AdeR homologs: implications for antimicrobial resistance and pathogenesis. | PLoS One | 2025 | https://conductscience.org/library/papers/40063617 | PubMed |
| 39936427 | Biological Evaluation and Computational Modelling Studies on N-acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/39936427 | PubMed |
| 39916696 | Structural characteristics, functions, and counteracting strategies of biofilms in Staphylococcus aureus. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/39916696 | PubMed |
| 39452196 | Activity of Organoboron Compounds against Biofilm-Forming Pathogens. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39452196 | PubMed |
| 39086984 | Exploring essential oil-based bio-composites: molecular docking and in vitro analysis for oral bacterial biofilm inhibition. | Front Chem | 2024 | https://conductscience.org/library/papers/39086984 | PubMed |
| 38967080 | Heterogenous Expression and Purification of Lipid II Flippase from Staphylococcus aureus. | Protein Pept Lett | 2024 | https://conductscience.org/library/papers/38967080 | PubMed |
| 38731617 | Synthesis, Electronic, and Antibacterial Properties of 3,7-Di(hetero)aryl-substituted Phenothiazinyl N-Propyl Trimethylammonium Salts. | Molecules | 2024 | https://conductscience.org/library/papers/38731617 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34480904
GET https://conductscience.org/api/papers/v1/34480904/cited_by?page=2